| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.989 | 0.002 | 0.989 | Histone deacetylase 1 inhibitor | |||
| 0.978 | 0.002 | 0.978 | Histone deacetylase 6 inhibitor | |||
| 0.977 | 0.002 | 0.977 | Histone deacetylase class IIb inhibitor | |||
| 0.972 | 0.002 | 0.972 | Histone deacetylase class II inhibitor | |||
| 0.97 | 0.002 | 0.97 | Histone deacetylase 2 inhibitor | |||
| 0.962 | 0.002 | 0.962 | Histone deacetylase 3 inhibitor | |||
| 0.927 | 0.002 | 0.927 | Histone deacetylase class IIa inhibitor | |||
| 0.913 | 0.002 | 0.913 | Histone deacetylase class IV inhibitor | |||
| 0.913 | 0.002 | 0.913 | Histone deacetylase 11 inhibitor | |||
| 0.91 | 0.002 | 0.91 | Histone deacetylase 5 inhibitor | |||
| 0.904 | 0.002 | 0.904 | Histone deacetylase 10 inhibitor | |||
| 0.856 | 0.002 | 0.856 | Histone deacetylase inhibitor | |||
| 0.832 | 0.002 | 0.832 | Histone deacetylase class I inhibitor | |||
| 0.733 | 0.005 | 0.733 | Tumour necrosis factor alpha release inhibitor | |||
| 0.711 | 0.002 | 0.711 | Histone deacetylase 8 inhibitor | |||
| 0.643 | 0.002 | 0.643 | Histone deacetylase 4 inhibitor | |||
| 0.625 | 0.004 | 0.625 | Peroxidase inhibitor | 0.469 0.012 DBMET00726 | ||
| 0.556 | 0.002 | 0.556 | Histone deacetylase 7 inhibitor | |||
| 0.53 | 0.002 | 0.53 | Histone deacetylase 9 inhibitor | |||
| 0.514 | 0.054 | 0.514 | Caspase 9 stimulant | 0.453 0.081 DBMET00726 | ||
| 0.509 | 0.072 | 0.509 | Apoptosis agonist | |||
| 0.415 | 0.02 | 0.415 | Insulysin inhibitor | 0.335 0.04 DBMET00726 | ||
| 0.386 | 0.004 | 0.386 | Urease inhibitor | 0.115 0.05 DBMET00726 | ||
| 0.421 | 0.055 | 0.421 | Immunosuppressant | |||
| 0.372 | 0.011 | 0.372 | DNA methyltransferase I inhibitor | 0.186 0.076 DBMET00726 | ||
| 0.357 | 0.016 | 0.357 | DNA methylase inhibitor | 0.183 0.091 DBMET00726 | ||
| 0.329 | 0.005 | 0.329 | Death-associated protein kinase 2 inhibitor | |||
| 0.294 | 0.019 | 0.294 | Tumour necrosis factor antagonist | |||
| 0.287 | 0.017 | 0.287 | Interleukin 6 antagonist | |||
| 0.301 | 0.032 | 0.33 | Gastrin inhibitor | 0.33 0.017 DBMET00726 | DBMET00726 | |
| 0.271 | 0.004 | 0.271 | Macrophage elastase inhibitor | 0.04 0.034 DBMET00726 | ||
| 0.277 | 0.01 | 0.277 | Aminopeptidase B inhibitor | 0.197 0.022 DBMET00726 | ||
| 0.277 | 0.015 | 0.277 | M17 leucyl aminopeptidase inhibitor | |||
| 0.264 | 0.006 | 0.356 | Triose-phosphate isomerase inhibitor | 0.356 0.004 DBMET00726 | DBMET00726 | |
| 0.256 | 0.003 | 0.256 | Aminopeptidase microsomal inhibitor | |||
| 0.268 | 0.017 | 0.268 | Adenylate cyclase inhibitor | 0.145 0.048 DBMET00726 | ||
| 0.249 | 0.009 | 0.249 | Carbonic anhydrase III inhibitor | 0.17 0.022 DBMET00726 | ||
| 0.343 | 0.106 | 0.47 | Antibacterial | 0.47 0.05 DBMET00726 | DBMET00726 | |
| 0.237 | 0.003 | 0.237 | Aminopeptidase N inhibitor | |||
| 0.236 | 0.003 | 0.236 | Collagenase inhibitor | |||
| 0.237 | 0.005 | 0.268 | Glutamate decarboxylase inhibitor | 0.268 0.004 DBMET00726 | DBMET00726 | |
| 0.269 | 0.039 | 0.365 | Growth hormone agonist | 0.365 0.021 DBMET00726 | DBMET00726 | |
| 0.288 | 0.062 | 0.288 | DNA damaging | 0.207 0.11 DBMET00726 | ||
| 0.345 | 0.12 | 0.417 | 5 Hydroxytryptamine release inhibitor | 0.417 0.068 DBMET00726 | DBMET00726 | |
| 0.228 | 0.008 | 0.228 | GABA C receptor antagonist | 0.181 0.017 DBMET00726 | ||
| 0.22 | 0.008 | 0.22 | Metalloproteinase-2 inhibitor | |||
| 0.353 | 0.148 | 0.365 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.365 0.135 DBMET00726 | DBMET00726 | |
| 0.209 | 0.008 | 0.209 | Sphingomyelinase inhibitor | |||
| 0.205 | 0.008 | 0.205 | Metalloproteinase-9 inhibitor | |||
| 0.255 | 0.064 | 0.376 | Tyrosine 3 hydroxylase inhibitor | 0.376 0.011 DBMET00726 | DBMET00726 | |
| 0.26 | 0.072 | 0.35 | Interleukin agonist | 0.35 0.029 DBMET00726 | DBMET00726 | |
| 0.269 | 0.087 | 0.269 | Lipoxygenase inhibitor | |||
| 0.2 | 0.022 | 0.444 | Ferrochelatase inhibitor | 0.444 0.003 DBMET00726 | DBMET00726 | |
| 0.182 | 0.005 | 0.182 | Phosphodiesterase 4C inhibitor | |||
| 0.183 | 0.011 | 0.183 | CDK3/cyclin E inhibitor | |||
| 0.183 | 0.012 | 0.183 | Death-associated protein kinase 1 inhibitor | |||
| 0.171 | 0.004 | 0.171 | Leukotriene A4 hydrolase inhibitor | 0.046 0.022 DBMET00726 | ||
| 0.175 | 0.011 | 0.175 | Matrix metalloproteinase inhibitor | |||
| 0.16 | 0.003 | 0.16 | ADAM10 endopeptidase inhibitor | |||
| 0.26 | 0.103 | 0.26 | 12-Lipoxygenase inhibitor | 0.192 0.16 DBMET00726 | ||
| 0.166 | 0.01 | 0.166 | Neutrophil collagenase inhibitor | |||
| 0.155 | 0.004 | 0.155 | Botulinum neurotoxin type A inhibitor | |||
| 0.186 | 0.038 | 0.408 | Alpha-N-acetylglucosaminidase inhibitor | 0.408 0.008 DBMET00726 | DBMET00726 | |
| 0.176 | 0.03 | 0.176 | 5-Lipoxygenase inhibitor | |||
| 0.203 | 0.069 | 0.301 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.301 0.023 DBMET00726 | DBMET00726 | |
| 0.13 | 0.003 | 0.13 | Immunoglobulin Fc receptor antagonist | |||
| 0.14 | 0.014 | 0.18 | Phenylalanine 4-hydroxylase inhibitor | 0.18 0.008 DBMET00726 | DBMET00726 | |
| 0.247 | 0.121 | 0.368 | Interleukin 2 agonist | 0.368 0.038 DBMET00726 | DBMET00726 | |
| 0.186 | 0.061 | 0.375 | Succinate dehydrogenase inhibitor | 0.375 0.005 DBMET00726 | DBMET00726 | |
| 0.13 | 0.01 | 0.13 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.26 | 0.146 | 0.435 | GABA C receptor rho-3 antagonist | 0.435 0.047 DBMET00726 | DBMET00726 | |
| 0.193 | 0.08 | 0.193 | Histone acetyltransferase inhibitor | |||
| 0.211 | 0.1 | 0.211 | Neuropeptide Y2 antagonist | 0.195 0.129 DBMET00726 | ||
| 0.133 | 0.023 | 0.133 | Phosphodiesterase 4D inhibitor | |||
| 0.111 | 0.004 | 0.111 | Dihydroorotate oxidase inhibitor | 0.052 0.045 DBMET00726 | ||
| 0.115 | 0.01 | 0.115 | Matrix metalloproteinase 1 inhibitor | |||
| 0.109 | 0.006 | 0.109 | Carbonic anhydrase IV inhibitor | 0.047 0.027 DBMET00726 | ||
| 0.113 | 0.011 | 0.113 | NMDA receptor glycine site agonist | 0.079 0.029 DBMET00726 | ||
| 0.115 | 0.013 | 0.115 | Collagenase 3 inhibitor | |||
| 0.191 | 0.089 | 0.191 | Interleukin antagonist | 0.153 0.116 DBMET00726 | ||
| 0.109 | 0.008 | 0.109 | Phosphodiesterase 1C inhibitor | |||
| 0.103 | 0.004 | 0.103 | Peptide deformylase inhibitor | |||
| 0.17 | 0.072 | 0.228 | Phospholipase C inhibitor | 0.228 0.031 DBMET00726 | DBMET00726 | |
| 0.12 | 0.023 | 0.12 | Glutathione S-transferase inhibitor | 0.12 0.022 DBMET00726 | ||
| 0.103 | 0.006 | 0.103 | Lysine-specific demethylase 1A inhibitor | |||
| 0.145 | 0.051 | 0.145 | Antibacterial (Helicobacter pylori) | 0.111 0.096 DBMET00726 | ||
| 0.144 | 0.05 | 0.144 | Alkylator | 0.121 0.067 DBMET00726 | ||
| 0.095 | 0.002 | 0.095 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.11 | 0.016 | 0.127 | NMDA receptor agonist | 0.127 0.012 DBMET00726 | DBMET00726 | |
| 0.094 | 0.005 | 0.094 | Adenylate cyclase 1 inhibitor | |||
| 0.095 | 0.005 | 0.115 | Glucose-6-phosphate isomerase inhibitor | 0.115 0.004 DBMET00726 | DBMET00726 | |
| 0.097 | 0.011 | 0.097 | Metalloproteinase-3 inhibitor | |||
| 0.129 | 0.044 | 0.629 | GABA C receptor agonist | 0.629 0.003 DBMET00726 | DBMET00726 | |
| 0.129 | 0.046 | 0.129 | Chelator | 0.116 0.058 DBMET00726 | ||
| 0.148 | 0.066 | 0.184 | Adenylate cyclase stimulant | 0.184 0.023 DBMET00726 | DBMET00726 | |
| 0.206 | 0.125 | 0.206 | Transcription factor STAT3 inhibitor | |||
| 0.086 | 0.006 | 0.086 | Inosine monophosphate dehydrogenase inhibitor | 0.036 0.025 DBMET00726 | ||
| 0.104 | 0.026 | 0.104 | Carbonic anhydrase V inhibitor | 0.081 0.035 DBMET00726 | ||
| 0.134 | 0.058 | 0.143 | DNA polymerase I inhibitor | 0.143 0.053 DBMET00726 | DBMET00726 | |
| 0.196 | 0.123 | 0.318 | Immunostimulant | 0.318 0.074 DBMET00726 | DBMET00726 | |
| 0.22 | 0.148 | 0.22 | Angiogenesis inhibitor | |||
| 0.098 | 0.026 | 0.098 | Carbonic anhydrase VA inhibitor | 0.088 0.031 DBMET00726 | ||
| 0.237 | 0.166 | 0.475 | Histamine release inhibitor | 0.475 0.038 DBMET00726 | DBMET00726 | |
| 0.253 | 0.184 | 0.253 | Transcription factor inhibitor | |||
| 0.19 | 0.123 | 0.19 | Calpain inhibitor | |||
| 0.125 | 0.059 | 0.125 | Interleukin 1b antagonist | |||
| 0.114 | 0.049 | 0.287 | Adenylate kinase inhibitor | 0.287 0.008 DBMET00726 | DBMET00726 | |
| 0.1 | 0.035 | 0.1 | Myeloperoxidase inhibitor | |||
| 0.13 | 0.066 | 0.151 | Vanilloid 1 agonist | 0.151 0.037 DBMET00726 | DBMET00726 | |
| 0.067 | 0.007 | 0.067 | Aggrecanase 1 inhibitor | |||
| 0.154 | 0.094 | 0.154 | ATPase inhibitor | |||
| 0.082 | 0.022 | 0.082 | Phosphodiesterase 1B inhibitor | |||
| 0.109 | 0.051 | 0.179 | GABA C receptor rho-1 antagonist | 0.179 0.012 DBMET00726 | DBMET00726 | |
| 0.082 | 0.024 | 0.082 | Carbonic anhydrase I inhibitor | |||
| 0.087 | 0.032 | 0.087 | Carbonic anhydrase inhibitor | |||
| 0.059 | 0.005 | 0.059 | Methionyl aminopeptidase 1 inhibitor | 0.031 0.024 DBMET00726 | ||
| 0.079 | 0.025 | 0.079 | Carbonic anhydrase II inhibitor | |||
| 0.133 | 0.082 | 0.17 | Cell wall synthesis inhibitor | 0.17 0.047 DBMET00726 | DBMET00726 | |
| 0.054 | 0.005 | 0.054 | Aggrecanase 2 inhibitor | |||
| 0.113 | 0.066 | 0.113 | Monophenol monooxygenase inhibitor | |||
| 0.06 | 0.014 | 0.06 | Glutamate (mGluR4) antagonist | 0.057 0.015 DBMET00726 | ||
| 0.073 | 0.027 | 0.073 | Ribonucleoside-diphosphate reductase inhibitor | 0.066 0.031 DBMET00726 | ||
| 0.057 | 0.012 | 0.073 | Membrane dipeptidase inhibitor | 0.073 0.006 DBMET00726 | DBMET00726 | |
| 0.074 | 0.029 | 0.074 | Ribonucleotide reductase inhibitor | 0.067 0.032 DBMET00726 | ||
| 0.08 | 0.037 | 0.08 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.046 | 0.004 | 0.046 | Purinergic P2Y15 antagonist | 0.027 0.023 DBMET00726 | ||
| 0.125 | 0.084 | 0.136 | Sphingosine 1-phosphate receptor 2 antagonist | 0.136 0.063 DBMET00726 | DBMET00726 | |
| 0.046 | 0.005 | 0.046 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.02 0.013 DBMET00726 | ||
| 0.096 | 0.057 | 0.096 | Toll-Like receptor 3 antagonist | |||
| 0.088 | 0.051 | 0.088 | Vanilloid agonist | |||
| 0.064 | 0.027 | 0.064 | Ryanodine receptor antagonist | 0.058 0.045 DBMET00726 | ||
| 0.066 | 0.03 | 0.066 | Carbonic anhydrase VB inhibitor | 0.06 0.035 DBMET00726 | ||
| 0.099 | 0.062 | 0.132 | UDP-glucose 4-epimerase inhibitor | 0.132 0.036 DBMET00726 | DBMET00726 | |
| 0.086 | 0.05 | 0.109 | Carbonic anhydrase VI inhibitor | 0.109 0.034 DBMET00726 | DBMET00726 | |
| 0.188 | 0.155 | 0.188 | Transcription factor STAT inhibitor | |||
| 0.042 | 0.009 | 0.042 | CDK4/cyclin D3 inhibitor | |||
| 0.083 | 0.052 | 0.095 | Glycine receptor antagonist | 0.095 0.037 DBMET00726 | DBMET00726 | |
| 0.056 | 0.027 | 0.056 | Endothelin-converting enzyme inhibitor | |||
| 0.092 | 0.063 | 0.321 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.321 0.005 DBMET00726 | DBMET00726 | |
| 0.055 | 0.028 | 0.086 | Lysophosphatidic acid 3 receptor antagonist | 0.086 0.008 DBMET00726 | DBMET00726 | |
| 0.132 | 0.107 | 0.169 | Ca2+-transporting ATPase inhibitor | 0.169 0.013 DBMET00726 | DBMET00726 | |
| 0.074 | 0.051 | 0.223 | Catalase inhibitor | 0.223 0.012 DBMET00726 | DBMET00726 | |
| 0.111 | 0.088 | 0.156 | Cyclooxygenase 3 inhibitor | 0.156 0.043 DBMET00726 | DBMET00726 | |
| 0.052 | 0.031 | 0.052 | Bombesin 2 receptor antagonist | 0.048 0.036 DBMET00726 | ||
| 0.028 | 0.007 | 0.028 | Aminopeptidase A inhibitor | 0.02 0.011 DBMET00726 | ||
| 0.069 | 0.048 | 0.241 | Phosphofructokinase-1 inhibitor | 0.241 0.008 DBMET00726 | DBMET00726 | |
| 0.037 | 0.017 | 0.037 | Dipeptidyl peptidase II inhibitor | |||
| 0.13 | 0.111 | 0.13 | Heat shock protein 90 alpha antagonist | |||
| 0.085 | 0.067 | 0.085 | Phosphodiesterase I inhibitor | |||
| 0.093 | 0.075 | 0.093 | Gastric antisecretory | |||
| 0.073 | 0.057 | 0.188 | GABA aminotransferase inhibitor | 0.188 0.005 DBMET00726 | DBMET00726 | |
| 0.05 | 0.035 | 0.05 | Phosphodiesterase 4A inhibitor | |||
| 0.073 | 0.059 | 0.113 | Keratolytic | 0.113 0.024 DBMET00726 | DBMET00726 | |
| 0.021 | 0.008 | 0.039 | Carbonic anhydrase X inhibitor | 0.039 0.003 DBMET00726 | DBMET00726 | |
| 0.021 | 0.008 | 0.039 | Carbonic anhydrase VIII inhibitor | 0.039 0.003 DBMET00726 | DBMET00726 | |
| 0.016 | 0.005 | 0.021 | Carbonic anhydrase XI inhibitor | 0.021 0.004 DBMET00726 | DBMET00726 | |
| 0.091 | 0.08 | 0.092 | Falcipain 3 inhibitor | 0.092 0.078 DBMET00726 | DBMET00726 | |
| 0.023 | 0.012 | 0.023 | Inosine monophosphate dehydrogenase 1 inhibitor | |||
| 0.045 | 0.035 | 0.055 | Adenosine deaminase inhibitor | 0.055 0.025 DBMET00726 | DBMET00726 | |
| 0.166 | 0.155 | 0.189 | Peptidyltransferase inhibitor | 0.189 0.114 DBMET00726 | DBMET00726 | |
| 0.069 | 0.058 | 0.325 | Glutamate dehydrogenase inhibitor | 0.325 0.005 DBMET00726 | DBMET00726 | |
| 0.055 | 0.045 | 0.074 | Leukotriene C antagonist | 0.074 0.011 DBMET00726 | DBMET00726 | |
| 0.187 | 0.179 | 0.364 | 5 Hydroxytryptamine uptake stimulant | 0.364 0.022 DBMET00726 | DBMET00726 | |
| 0.051 | 0.043 | 0.067 | Heparanase inhibitor | 0.067 0.014 DBMET00726 | DBMET00726 | |
| 0.042 | 0.035 | 0.05 | Glutamate (mGluR group III) antagonist | 0.05 0.02 DBMET00726 | DBMET00726 | |
| 0.056 | 0.05 | 0.056 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.085 | 0.079 | 0.085 | MAP kinase kinase 1 inhibitor | |||
| 0.066 | 0.062 | 0.087 | Carbonic anhydrase XIII inhibitor | 0.087 0.045 DBMET00726 | DBMET00726 | |
| 0.137 | 0.133 | 0.137 | MAP kinase kinase 2 inhibitor | |||
| 0.058 | 0.055 | 0.058 | Histone deacetylase SIRT3 inhibitor | |||
| 0.078 | 0.075 | 0.091 | D-Ala-D-Ala ligase inhibitor | 0.091 0.042 DBMET00726 | DBMET00726 | |
| 0.114 | 0.111 | 0.22 | Mannose-6-phosphate isomerase inhibitor | 0.22 0.021 DBMET00726 | DBMET00726 | |
| 0.005 | 0.004 | 0.005 | Bone morphogenic protein 1 inhibitor | |||
| 0.015 | 0.015 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 DBMET00726 | DBMET00726 | |
| 0.033 | 0.036 | 0.041 | Kainate receptor antagonist | 0.041 0.028 DBMET00726 | DBMET00726 | |
| 0.029 | 0.032 | 0.047 | Arginase inhibitor | 0.047 0.017 DBMET00726 | DBMET00726 | |
| 0.045 | 0.048 | 0.259 | Aconitate hydratase inhibitor | 0.259 0.003 DBMET00726 | DBMET00726 | |
| 0.045 | 0.05 | 0.113 | Acyl-CoA dehydrogenase inhibitor | 0.113 0.014 DBMET00726 | DBMET00726 | |
| 0.07 | 0.076 | 0.107 | ErbB-3 antagonist | 0.107 0.036 DBMET00726 | DBMET00726 | |
| 0.035 | 0.041 | 0.05 | Leukotriene C4 antagonist | 0.05 0.01 DBMET00726 | DBMET00726 | |
| 0.021 | 0.028 | 0.035 | Lysophosphatidic acid receptor 1 agonist | 0.035 0.008 DBMET00726 | DBMET00726 | |
| 0.119 | 0.127 | 0.137 | Sphingosine 1-phosphate receptor 5 antagonist | 0.137 0.085 DBMET00726 | DBMET00726 | |
| 0.134 | 0.142 | 0.151 | Non-steroidal antiinflammatory agent | 0.151 0.114 DBMET00726 | DBMET00726 | |
| 0.044 | 0.052 | 0.077 | CD45 antagonist | 0.077 0.013 DBMET00726 | DBMET00726 | |
| 0.009 | 0.019 | 0.023 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.023 0.006 DBMET00726 | DBMET00726 | |
| 0.093 | 0.103 | 0.147 | TRPA1 agonist | 0.147 0.033 DBMET00726 | DBMET00726 | |
| 0.036 | 0.047 | 0.062 | Antimetabolite | 0.062 0.025 DBMET00726 | DBMET00726 | |
| 0.011 | 0.024 | 0.028 | Thromboxane A2 agonist | 0.028 0.004 DBMET00726 | DBMET00726 | |
| 0.134 | 0.148 | 0.257 | Catenin beta inhibitor | 0.257 0.01 DBMET00726 | DBMET00726 | |
| 0.061 | 0.077 | 0.11 | Glycine receptor agonist | 0.11 0.016 DBMET00726 | DBMET00726 | |
| 0.138 | 0.156 | 0.186 | Neurotrophic factor enhancer | 0.186 0.092 DBMET00726 | DBMET00726 | |
| 0.058 | 0.076 | 0.116 | Glutamate (mGluR6) antagonist | 0.116 0.006 DBMET00726 | DBMET00726 | |
| 0.044 | 0.064 | 0.211 | Biliverdin reductase inhibitor | 0.211 0.005 DBMET00726 | DBMET00726 | |
| 0.119 | 0.138 | 0.139 | Melanin inhibitor | 0.139 0.098 DBMET00726 | DBMET00726 | |
| 0.036 | 0.057 | 0.102 | Ornithine carbamoyltransferase inhibitor | 0.102 0.016 DBMET00726 | DBMET00726 | |
| 0.007 | 0.027 | 0.015 | Lysophosphatidic acid receptor 3 agonist | 0.015 0.008 DBMET00726 | DBMET00726 | |
| 0.044 | 0.066 | 0.243 | Carbamoyl phosphate synthetase inhibitor | 0.243 0.005 DBMET00726 | DBMET00726 | |
| 0.034 | 0.057 | 0.087 | AICAR transformylase inhibitor | 0.087 0.006 DBMET00726 | DBMET00726 | |
| 0.033 | 0.057 | 0.058 | Kainate receptor agonist | 0.058 0.008 DBMET00726 | DBMET00726 | |
| 0.065 | 0.089 | 0.125 | GABA B receptor agonist | 0.125 0.006 DBMET00726 | DBMET00726 | |
| 0.021 | 0.045 | 0.049 | Kainate receptor 2 antagonist | 0.049 0.017 DBMET00726 | DBMET00726 | |
| 0.03 | 0.054 | 0.082 | Glutamate (mGluR8) agonist | 0.082 0.004 DBMET00726 | DBMET00726 | |
| 0.099 | 0.124 | 0.13 | Sphingosine 1-phosphate receptor 4 antagonist | 0.13 0.055 DBMET00726 | DBMET00726 | |
| 0.033 | 0.059 | 0.041 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.031 DBMET00726 | DBMET00726 | |
| 0.027 | 0.053 | 0.052 | Dihydropteroate synthase inhibitor | 0.052 0.015 DBMET00726 | DBMET00726 | |
| 0.043 | 0.07 | 0.084 | Carbonic anhydrase stimulant | 0.084 0.024 DBMET00726 | DBMET00726 | |
| 0.018 | 0.045 | 0.025 | Thyroid hormone agonist | 0.025 0.019 DBMET00726 | DBMET00726 | |
| 0.095 | 0.124 | 0.105 | Transcription factor STAT6 inhibitor | 0.105 0.094 DBMET00726 | DBMET00726 | |
| 0.076 | 0.107 | 0.127 | Anabolic | 0.127 0.033 DBMET00726 | DBMET00726 | |
| 0.042 | 0.073 | 0.08 | Thromboxane synthase inhibitor | 0.08 0.012 DBMET00726 | DBMET00726 | |
| 0.018 | 0.049 | 0.028 | Glutamate (mGluR1) agonist | 0.028 0.011 DBMET00726 | DBMET00726 | |
| 0.091 | 0.122 | 0.221 | Toll-Like receptor 2 antagonist | 0.221 0.016 DBMET00726 | DBMET00726 | |
| 0.02 | 0.052 | 0.037 | Lysophosphatidic acid 2 receptor antagonist | 0.037 0.014 DBMET00726 | DBMET00726 | |
| 0.052 | 0.086 | 0.138 | Aminopeptidase I inhibitor | 0.138 0.015 DBMET00726 | DBMET00726 | |
| 0.036 | 0.072 | 0.245 | Alcohol oxidase inhibitor | 0.245 0.005 DBMET00726 | DBMET00726 | |
| 0.175 | 0.212 | 0.322 | Antithrombotic | 0.322 0.075 DBMET00726 | DBMET00726 | |
| 0.096 | 0.132 | 0.168 | Protein kinase stimulant | 0.168 0.057 DBMET00726 | DBMET00726 | |
| 0.075 | 0.116 | 0.111 | Interleukin 12 antagonist | 0.111 0.038 DBMET00726 | DBMET00726 | |
| 0.113 | 0.154 | 0.202 | Interferon gamma antagonist | 0.202 0.04 DBMET00726 | DBMET00726 | |
| 0.012 | 0.055 | 0.022 | Caspase 8 inhibitor | 0.022 0.01 DBMET00726 | DBMET00726 | |
| 0.125 | 0.169 | 0.25 | Insulin sensitizer | 0.25 0.034 DBMET00726 | DBMET00726 | |
| 0.003 | 0.047 | 0.009 | Integrin alpha5beta6 antagonist | 0.009 0.004 DBMET00726 | DBMET00726 | |
| 0.018 | 0.063 | 0.138 | Fumarate hydratase inhibitor | 0.138 0.004 DBMET00726 | DBMET00726 | |
| 0.013 | 0.058 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DBMET00726 | DBMET00726 | |
| 0.013 | 0.061 | 0.059 | Lysine carboxypeptidase inhibitor | 0.059 0.006 DBMET00726 | DBMET00726 | |
| 0.104 | 0.152 | 0.217 | Arachidonic acid antagonist | 0.217 0.019 DBMET00726 | DBMET00726 | |
| 0.066 | 0.115 | 0.157 | NADH dehydrogenase inhibitor | 0.157 0.016 DBMET00726 | DBMET00726 | |
| 0.022 | 0.071 | 0.035 | Carboxypeptidase B inhibitor | 0.035 0.019 DBMET00726 | DBMET00726 | |
| 0.045 | 0.096 | 0.498 | Porphobilinogen synthase inhibitor | 0.498 0.003 DBMET00726 | DBMET00726 | |
| 0.025 | 0.077 | 0.076 | Thromboxane A2 antagonist | 0.076 0.018 DBMET00726 | DBMET00726 | |
| 0.015 | 0.067 | 0.041 | Caspase 2 inhibitor | 0.041 0.015 DBMET00726 | DBMET00726 | |
| 0.021 | 0.074 | 0.056 | Toll-Like receptor 2 agonist | 0.056 0.021 DBMET00726 | DBMET00726 | |
| 0.026 | 0.079 | 0.051 | AMPA 4 receptor antagonist | 0.051 0.015 DBMET00726 | DBMET00726 | |
| 0.009 | 0.063 | 0.032 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.032 0.016 DBMET00726 | DBMET00726 | |
| 0.022 | 0.077 | 0.036 | Retinoid X alpha receptor antagonist | 0.036 0.02 DBMET00726 | DBMET00726 | |
| 0.075 | 0.131 | 0.111 | Toll-Like receptor 4 antagonist | 0.111 0.054 DBMET00726 | DBMET00726 | |
| 0.027 | 0.084 | 0.08 | Thromboxane antagonist | 0.08 0.02 DBMET00726 | DBMET00726 | |
| 0.117 | 0.174 | 0.253 | Lipocortins synthesis antagonist | 0.253 0.032 DBMET00726 | DBMET00726 | |
| 0.022 | 0.079 | 0.043 | Glutamate (mGluR3) agonist | 0.043 0.008 DBMET00726 | DBMET00726 | |
| 0.034 | 0.091 | 0.061 | Selectin antagonist | 0.061 0.048 DBMET00726 | DBMET00726 | |
| 0.004 | 0.061 | 0.015 | Thromboxane agonist | 0.015 0.005 DBMET00726 | DBMET00726 | |
| 0.048 | 0.106 | 0.09 | Glutamate (mGluR7) antagonist | 0.09 0.017 DBMET00726 | DBMET00726 | |
| 0.034 | 0.092 | 0.054 | Alpha-mannosidase inhibitor | 0.054 0.036 DBMET00726 | DBMET00726 | |
| 0.024 | 0.083 | 0.044 | Retinoid X receptor antagonist | 0.044 0.019 DBMET00726 | DBMET00726 | |
| 0.036 | 0.095 | 0.059 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.059 0.04 DBMET00726 | DBMET00726 | |
| 0.016 | 0.076 | 0.036 | Calcitonin receptor agonist | 0.036 0.022 DBMET00726 | DBMET00726 | |
| 0.04 | 0.101 | 0.102 | Purinergic P2X1 antagonist | 0.102 0.016 DBMET00726 | DBMET00726 | |
| 0.01 | 0.073 | 0.043 | Glutamate (mGluR1a) agonist | 0.043 0.005 DBMET00726 | DBMET00726 | |
| 0.056 | 0.12 | 0.1 | Epidermal growth factor antagonist | 0.1 0.045 DBMET00726 | DBMET00726 | |
| 0.04 | 0.106 | 0.167 | Histidine decarboxylase inhibitor | 0.167 0.017 DBMET00726 | DBMET00726 | |
| 0.067 | 0.133 | 0.094 | Hematopoietic | 0.094 0.043 DBMET00726 | DBMET00726 | |
| 0.004 | 0.07 | 0.02 | Glutamate (mGluR6) agonist | 0.02 0.004 DBMET00726 | DBMET00726 | |
| 0.024 | 0.09 | 0.052 | Mannosidase inhibitor | 0.052 0.023 DBMET00726 | DBMET00726 | |
| 0.032 | 0.099 | 0.06 | Leukotriene B4 antagonist | 0.06 0.028 DBMET00726 | DBMET00726 | |
| 0.102 | 0.171 | 0.177 | GABA C receptor rho-2 antagonist | 0.177 0.044 DBMET00726 | DBMET00726 | |
| 0.082 | 0.151 | 0.125 | Cathepsin H inhibitor | 0.125 0.07 DBMET00726 | DBMET00726 | |
| 0.148 | 0.218 | 0.199 | Nitric-oxide synthase stimulant | 0.199 0.091 DBMET00726 | DBMET00726 | |
| 0.078 | 0.148 | 0.199 | Photosensitizer | 0.199 0.013 DBMET00726 | DBMET00726 | |
| 0.12 | 0.191 | 0.155 | Heat shock protein 70 antagonist | 0.155 0.035 DBMET00726 | DBMET00726 | |
| 0.012 | 0.083 | 0.036 | Prostaglandin F2 alpha agonist | 0.036 0.006 DBMET00726 | DBMET00726 | |
| 0.138 | 0.21 | 0.297 | Superoxide dismutase inhibitor | 0.297 0.051 DBMET00726 | DBMET00726 | |
| 0.028 | 0.101 | 0.167 | Argininosuccinate synthase inhibitor | 0.167 0.01 DBMET00726 | DBMET00726 | |
| 0.091 | 0.165 | 0.18 | Phospholipase A2 inhibitor | 0.18 0.054 DBMET00726 | DBMET00726 | |
| 0.12 | 0.195 | 0.19 | Neurotensin receptor agonist | 0.19 0.041 DBMET00726 | DBMET00726 | |
| 0.022 | 0.098 | 0.081 | Thymidylate synthase inhibitor | 0.081 0.007 DBMET00726 | DBMET00726 | |
| 0.021 | 0.098 | 0.038 | Glutamate (mGluR4) agonist | 0.038 0.017 DBMET00726 | DBMET00726 | |
| 0.055 | 0.133 | 0.084 | Vanilloid 4 agonist | 0.084 0.035 DBMET00726 | DBMET00726 | |
| 0.034 | 0.117 | 0.075 | Leukotriene antagonist | 0.075 0.036 DBMET00726 | DBMET00726 | |
| 0.009 | 0.094 | 0.025 | Integrin alphaVbeta3 antagonist | 0.025 0.012 DBMET00726 | DBMET00726 | |
| 0.01 | 0.094 | 0.04 | AMPA 3 receptor antagonist | 0.04 0.014 DBMET00726 | DBMET00726 | |
| 0.173 | 0.259 | 0.226 | Calcium channel activator | 0.226 0.176 DBMET00726 | DBMET00726 | |
| 0.064 | 0.15 | 0.102 | Estrogen-related receptor beta agonist | 0.102 0.023 DBMET00726 | DBMET00726 | |
| 0.037 | 0.126 | 0.066 | Na+ K+ transporting ATPase inhibitor | 0.066 0.064 DBMET00726 | DBMET00726 | |
| 0.139 | 0.229 | 0.214 | RNA-directed DNA polymerase inhibitor | 0.214 0.081 DBMET00726 | DBMET00726 | |
| 0.07 | 0.16 | 0.115 | Glutamate (mGluR7) agonist | 0.115 0.035 DBMET00726 | DBMET00726 | |
| 0.024 | 0.116 | 0.107 | NMDA 2C receptor antagonist | 0.107 0.014 DBMET00726 | DBMET00726 | |
| 0.021 | 0.115 | 0.06 | NMDA receptor subunit 3B antagonist | 0.06 0.019 DBMET00726 | DBMET00726 | |
| 0.06 | 0.154 | 0.18 | Cystathionine beta-synthase inhibitor | 0.18 0.03 DBMET00726 | DBMET00726 | |
| 0.158 | 0.253 | 0.406 | Sodium/bile acid cotransporter inhibitor | 0.406 0.015 DBMET00726 | DBMET00726 | |
| 0.06 | 0.156 | 0.11 | Lanosterol 14 alpha demethylase inhibitor | 0.11 0.042 DBMET00726 | DBMET00726 | |
| 0.011 | 0.11 | 0.023 | Retinoid X beta receptor antagonist | 0.023 0.009 DBMET00726 | DBMET00726 | |
| 0.053 | 0.153 | 0.154 | Creatine kinase inhibitor | 0.154 0.022 DBMET00726 | DBMET00726 | |
| 0.023 | 0.123 | 0.041 | Thymidine kinase inhibitor | 0.041 0.029 DBMET00726 | DBMET00726 | |
| 0.028 | 0.13 | 0.08 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.08 0.02 DBMET00726 | DBMET00726 | |
| 0.052 | 0.155 | 0.131 | Prolactin inhibitor | 0.131 0.031 DBMET00726 | DBMET00726 | |
| 0.051 | 0.154 | 0.155 | HIV-1 integrase (Overall Integration) inhibitor | 0.155 0.023 DBMET00726 | DBMET00726 | |
| 0.014 | 0.117 | 0.042 | NMDA receptor subunit 3A antagonist | 0.042 0.024 DBMET00726 | DBMET00726 | |
| 0.059 | 0.165 | 0.102 | Granulocyte macrophage colony stimulating factor agonist | 0.102 0.032 DBMET00726 | DBMET00726 | |
| 0.024 | 0.132 | 0.036 | Vanilloid 3 antagonist | 0.036 0.033 DBMET00726 | DBMET00726 | |
| 0.064 | 0.174 | 0.157 | Caspase 3 inhibitor | 0.157 0.023 DBMET00726 | DBMET00726 | |
| 0.01 | 0.122 | 0.033 | 5-Alpha-reductase inhibitor | 0.033 0.031 DBMET00726 | DBMET00726 | |
| 0.011 | 0.125 | 0.031 | Phosphoglycerate kinase inhibitor | 0.031 0.03 DBMET00726 | DBMET00726 | |
| 0.016 | 0.13 | 0.04 | Glycine transporter 2 inhibitor | 0.04 0.039 DBMET00726 | DBMET00726 | |
| 0.037 | 0.152 | 0.061 | Protease 3C (Human rhinovirus) inhibitor | 0.061 0.051 DBMET00726 | DBMET00726 | |
| 0.016 | 0.132 | 0.047 | Glutamate (mGluR3) antagonist | 0.047 0.014 DBMET00726 | DBMET00726 | |
| 0.005 | 0.121 | 0.026 | Cholecystokinin B antagonist | 0.026 0.025 DBMET00726 | DBMET00726 | |
| 0.009 | 0.127 | 0.022 | Lysophosphatidic acid 1 receptor antagonist | 0.022 0.013 DBMET00726 | DBMET00726 | |
| 0.022 | 0.142 | 0.05 | Glutamate (mGluR group III) agonist | 0.05 0.024 DBMET00726 | DBMET00726 | |
| 0.076 | 0.197 | 0.164 | Psychostimulant | 0.164 0.104 DBMET00726 | DBMET00726 | |
| 0.074 | 0.198 | 0.278 | Angiogenesis stimulant | 0.278 0.058 DBMET00726 | DBMET00726 | |
| 0.034 | 0.16 | 0.094 | Phospholipase D inhibitor | 0.094 0.018 DBMET00726 | DBMET00726 | |
| 0.007 | 0.133 | 0.03 | Uridine phosphorylase inhibitor | 0.03 0.018 DBMET00726 | DBMET00726 | |
| 0.065 | 0.193 | 0.146 | DOPA decarboxylase inhibitor | 0.146 0.023 DBMET00726 | DBMET00726 | |
| 0.004 | 0.133 | 0.035 | Prostaglandin H2 antagonist | 0.035 0.009 DBMET00726 | DBMET00726 | |
| 0.111 | 0.242 | 0.179 | Cyclic AMP phosphodiesterase inhibitor | 0.179 0.112 DBMET00726 | DBMET00726 | |
| 0.083 | 0.215 | 0.253 | Anesthetic general | 0.253 0.049 DBMET00726 | DBMET00726 | |
| 0.037 | 0.17 | 0.067 | Interferon inducer | 0.067 0.039 DBMET00726 | DBMET00726 | |
| 0.067 | 0.202 | 0.105 | Acetylcholine release stimulant | 0.105 0.077 DBMET00726 | DBMET00726 | |
| 0.007 | 0.141 | 0.028 | Leukotriene B4 receptor 1 antagonist | 0.028 0.019 DBMET00726 | DBMET00726 | |
| 0.057 | 0.192 | 0.146 | Mucolytic | 0.146 0.035 DBMET00726 | DBMET00726 | |
| 0.017 | 0.152 | 0.041 | Integrin alpha2 antagonist | 0.041 0.019 DBMET00726 | DBMET00726 | |
| 0.014 | 0.153 | 0.029 | Caspase 6 inhibitor | 0.029 0.024 DBMET00726 | DBMET00726 | |
| 0.012 | 0.153 | 0.041 | ATP citrate lysase inhibitor | 0.041 0.012 DBMET00726 | DBMET00726 | |
| 0.055 | 0.196 | 0.172 | Electrolyte absorption antagonist | 0.172 0.013 DBMET00726 | DBMET00726 | |
| 0.059 | 0.201 | 0.103 | Microtubule formation inhibitor | 0.103 0.085 DBMET00726 | DBMET00726 | |
| 0.007 | 0.149 | 0.039 | Cholecystokinin antagonist | 0.039 0.03 DBMET00726 | DBMET00726 | |
| 0.053 | 0.196 | 0.097 | Transcription factor NF kappa B stimulant | 0.097 0.042 DBMET00726 | DBMET00726 | |
| 0.005 | 0.149 | 0.035 | Cholecystokinin A antagonist | 0.035 0.028 DBMET00726 | DBMET00726 | |
| 0.038 | 0.183 | 0.089 | Interferon agonist | 0.089 0.039 DBMET00726 | DBMET00726 | |
| 0.018 | 0.164 | 0.047 | Dihydrofolate reductase inhibitor | 0.047 0.023 DBMET00726 | DBMET00726 | |
| 0.176 | 0.321 | 0.235 | Calcium channel L-type activator | 0.235 0.222 DBMET00726 | DBMET00726 | |
| 0.065 | 0.212 | 0.204 | Folate antagonist | 0.204 0.009 DBMET00726 | DBMET00726 | |
| 0.081 | 0.228 | 0.121 | DNA repair enzyme inhibitor | 0.121 0.07 DBMET00726 | DBMET00726 | |
| 0.077 | 0.228 | 0.121 | Hexokinase inhibitor | 0.121 0.117 DBMET00726 | DBMET00726 | |
| 0.072 | 0.226 | 0.176 | Pyruvate kinase inhibitor | 0.176 0.096 DBMET00726 | DBMET00726 | |
| 0.069 | 0.224 | 0.108 | Factor V inhibitor | 0.108 0.054 DBMET00726 | DBMET00726 | |
| 0.12 | 0.275 | 0.266 | DNA synthesis inhibitor | 0.266 0.057 DBMET00726 | DBMET00726 | |
| 0.117 | 0.272 | 0.206 | Transcription factor NF kappa B inhibitor | 0.206 0.163 DBMET00726 | DBMET00726 | |
| 0.007 | 0.164 | 0.039 | Retinoid X receptor agonist | 0.039 0.023 DBMET00726 | DBMET00726 | |
| 0.016 | 0.174 | 0.042 | Cholecystokinin B agonist | 0.042 0.021 DBMET00726 | DBMET00726 | |
| 0.01 | 0.168 | 0.042 | Retinoid X alpha receptor agonist | 0.042 0.018 DBMET00726 | DBMET00726 | |
| 0.112 | 0.275 | 0.17 | 5 Hydroxytryptamine release stimulant | 0.17 0.152 DBMET00726 | DBMET00726 | |
| 0.059 | 0.226 | 0.12 | Glutamate release inhibitor | 0.12 0.022 DBMET00726 | DBMET00726 | |
| 0.007 | 0.175 | 0.021 | Integrin beta5 antagonist | 0.021 0.014 DBMET00726 | DBMET00726 | |
| 0.118 | 0.287 | 0.466 | Cholesterol antagonist | 0.466 0.038 DBMET00726 | DBMET00726 | |
| 0.007 | 0.178 | 0.021 | Integrin alphaVbeta1 antagonist | 0.021 0.011 DBMET00726 | DBMET00726 | |
| 0.034 | 0.207 | 0.101 | Ornithine decarboxylase inhibitor | 0.101 0.043 DBMET00726 | DBMET00726 | |
| 0.01 | 0.189 | 0.038 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.038 0.019 DBMET00726 | DBMET00726 | |
| 0.062 | 0.242 | 0.121 | Histone deacetylase SIRT1 inhibitor | 0.121 0.09 DBMET00726 | DBMET00726 | |
| 0.022 | 0.205 | 0.128 | Sphingosine 1-phosphate receptor 4 agonist | 0.128 0.014 DBMET00726 | DBMET00726 | |
| 0.012 | 0.196 | 0.051 | GABA uptake inhibitor | 0.051 0.015 DBMET00726 | DBMET00726 | |
| 0.005 | 0.189 | 0.019 | Vitronectin receptor antagonist | 0.019 0.016 DBMET00726 | DBMET00726 | |
| 0.005 | 0.19 | 0.054 | GP IIb/IIIa receptor antagonist | 0.054 0.03 DBMET00726 | DBMET00726 | |
| 0.006 | 0.195 | 0.037 | Prostaglandin agonist | 0.037 0.015 DBMET00726 | DBMET00726 | |
| 0.018 | 0.209 | 0.045 | Diacylglycerol O-acyltransferase inhibitor | 0.045 0.043 DBMET00726 | DBMET00726 | |
| 0.036 | 0.228 | 0.123 | Expectorant | 0.123 0.048 DBMET00726 | DBMET00726 | |
| 0.116 | 0.309 | 0.316 | Vasodilator, peripheral | 0.316 0.089 DBMET00726 | DBMET00726 | |
| 0.044 | 0.238 | 0.111 | Bile acid receptor antagonist | 0.111 0.03 DBMET00726 | DBMET00726 | |
| 0.027 | 0.222 | 0.111 | Cathepsin G inhibitor | 0.111 0.029 DBMET00726 | DBMET00726 | |
| 0.002 | 0.212 | 0.008 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.008 0.004 DBMET00726 | DBMET00726 | |
| 0.004 | 0.217 | 0.024 | Prostaglandin EP2 agonist | 0.024 0.015 DBMET00726 | DBMET00726 | |
| 0.018 | 0.239 | 0.046 | Glutamate (mGluR8) antagonist | 0.046 0.011 DBMET00726 | DBMET00726 | |
| 0.043 | 0.265 | 0.147 | Amylase inhibitor | 0.147 0.066 DBMET00726 | DBMET00726 | |
| 0.063 | 0.289 | 0.135 | Thiol protease inhibitor | 0.135 0.088 DBMET00726 | DBMET00726 | |
| 0.009 | 0.235 | 0.087 | Prostaglandin EP2 antagonist | 0.087 0.023 DBMET00726 | DBMET00726 | |
| 0.026 | 0.252 | 0.057 | Pregnane X receptor antagonist | 0.057 0.038 DBMET00726 | DBMET00726 | |
| 0.051 | 0.278 | 0.18 | Aldehyde dehydrogenase inhibitor | 0.18 0.034 DBMET00726 | DBMET00726 | |
| 0.023 | 0.251 | 0.053 | Sphingosine 1-phosphate receptor 1 antagonist | 0.053 0.045 DBMET00726 | DBMET00726 | |
| 0.005 | 0.233 | 0.047 | Kynurenine 3 monooxygenase inhibitor | 0.047 0.007 DBMET00726 | DBMET00726 | |
| 0.008 | 0.237 | 0.052 | Purinergic P2Y antagonist | 0.052 0.024 DBMET00726 | DBMET00726 | |
| 0.002 | 0.231 | 0.013 | Prostaglandin EP4 agonist | 0.013 0.012 DBMET00726 | DBMET00726 | |
| 0.067 | 0.299 | 0.388 | Aldehyde oxidase inhibitor | 0.388 0.049 DBMET00726 | DBMET00726 | |
| 0.006 | 0.239 | 0.017 | Integrin beta6 antagonist | 0.017 0.005 DBMET00726 | DBMET00726 | |
| 0.032 | 0.266 | 0.092 | Caspase 9 inhibitor | 0.092 0.017 DBMET00726 | DBMET00726 | |
| 0.003 | 0.237 | 0.024 | Prostaglandin E2 agonist | 0.024 0.015 DBMET00726 | DBMET00726 | |
| 0.018 | 0.257 | 0.055 | GABA B receptor antagonist | 0.055 0.016 DBMET00726 | DBMET00726 | |
| 0.027 | 0.269 | 0.198 | Alcohol dehydrogenase inhibitor | 0.198 0.013 DBMET00726 | DBMET00726 | |
| 0.036 | 0.278 | 0.157 | Interleukin 1 beta converting enzyme inhibitor | 0.157 0.014 DBMET00726 | DBMET00726 | |
| 0.021 | 0.28 | 0.046 | Integrin alpha1beta1 antagonist | 0.046 0.011 DBMET00726 | DBMET00726 | |
| 0.007 | 0.268 | 0.041 | Guanylate cyclase inhibitor | 0.041 0.031 DBMET00726 | DBMET00726 | |
| 0.03 | 0.292 | 0.072 | Sphingosine 1-phosphate receptor antagonist | 0.072 0.064 DBMET00726 | DBMET00726 | |
| 0.029 | 0.294 | 0.16 | Cholesterol synthesis inhibitor | 0.16 0.04 DBMET00726 | DBMET00726 | |
| 0.02 | 0.289 | 0.04 | Glucagon-like peptide 1 receptor antagonist | 0.04 0.027 DBMET00726 | DBMET00726 | |
| 0.002 | 0.272 | 0.019 | G-protein-coupled receptor 120 agonist | 0.019 0.01 DBMET00726 | DBMET00726 | |
| 0.026 | 0.3 | 0.06 | DNA helicase inhibitor | 0.06 0.027 DBMET00726 | DBMET00726 | |
| 0.106 | 0.403 | 0.297 | Apoptosis antagonist | 0.297 0.088 DBMET00726 | DBMET00726 | |
| 0.014 | 0.326 | 0.037 | VCAM antagonist | 0.037 0.036 DBMET00726 | DBMET00726 | |
| 0.014 | 0.326 | 0.037 | VCAM-1 antagonist | 0.037 0.036 DBMET00726 | DBMET00726 | |
| 0.061 | 0.375 | 0.186 | Antioxidant | 0.186 0.126 DBMET00726 | DBMET00726 | |
| 0.025 | 0.339 | 0.097 | Caspase 7 inhibitor | 0.097 0.032 DBMET00726 | DBMET00726 | |
| 0.037 | 0.353 | 0.077 | MDM2 inhibitor | 0.077 0.024 DBMET00726 | DBMET00726 | |
| 0.004 | 0.321 | 0.045 | Free fatty acid receptor 1 antagonist | 0.045 0.012 DBMET00726 | DBMET00726 | |
| 0.043 | 0.36 | 0.113 | Interleukin 8 antagonist | 0.113 0.071 DBMET00726 | DBMET00726 | |
| 0.011 | 0.331 | 0.067 | Plasminogen activator inhibitor antagonist | 0.067 0.02 DBMET00726 | DBMET00726 | |
| 0.005 | 0.33 | 0.038 | Sphingosine 1-phosphate receptor 1 agonist | 0.038 0.037 DBMET00726 | DBMET00726 | |
| 0.032 | 0.367 | 0.111 | Thioredoxin inhibitor | 0.111 0.037 DBMET00726 | DBMET00726 | |
| 0.024 | 0.367 | 0.073 | Peroxisome proliferator-activated receptor gamma antagonist | 0.073 0.047 DBMET00726 | DBMET00726 | |
| 0.005 | 0.359 | 0.041 | Integrin antagonist | 0.041 0.031 DBMET00726 | DBMET00726 | |
| 0.004 | 0.369 | 0.035 | Urate transporter 1 inhibitor | 0.035 0.033 DBMET00726 | DBMET00726 | |
| 0.011 | 0.376 | 0.036 | Tryptophan 5 hydroxylase inhibitor | 0.036 0.025 DBMET00726 | DBMET00726 | |
| 0.004 | 0.372 | 0.031 | HMG CoA reductase inhibitor | 0.031 0.03 DBMET00726 | DBMET00726 | |
| 0.013 | 0.386 | 0.071 | CDC25A inhibitor | 0.071 0.055 DBMET00726 | DBMET00726 | |
| 0.019 | 0.393 | 0.119 | Macrophage migration inhibitory factor inhibitor | 0.119 0.026 DBMET00726 | DBMET00726 | |
| 0.073 | 0.465 | 0.213 | Immunomodulator | 0.213 0.148 DBMET00726 | DBMET00726 | |
| 0.022 | 0.444 | 0.156 | Diuretic | 0.156 0.073 DBMET00726 | DBMET00726 | |
| 0.003 | 0.427 | 0.022 | Prostacyclin agonist | 0.022 0.008 DBMET00726 | DBMET00726 | |
| 0.032 | 0.474 | 0.37 | Platelet antagonist | 0.37 0.033 DBMET00726 | DBMET00726 | |
| 0.044 | 0.506 | 0.13 | NOS3 expression enhancer | 0.13 0.098 DBMET00726 | DBMET00726 | |
| 0.004 | 0.526 | 0.05 | Prostacyclin antagonist | 0.05 0.013 DBMET00726 | DBMET00726 | |
| 0.004 | 0.536 | 0.044 | Prostaglandin D2 agonist | 0.044 0.01 DBMET00726 | DBMET00726 | |
| 0.005 | 0.544 | 0.066 | Glucagon-like peptide 1 agonist | 0.066 0.044 DBMET00726 | DBMET00726 | |
| 0.012 | 0.563 | 0.096 | Prostaglandin F2 alpha antagonist | 0.096 0.013 DBMET00726 | DBMET00726 | |
| 0.022 | 0.58 | 0.182 | Platelet aggregation inhibitor | 0.182 0.096 DBMET00726 | DBMET00726 | |
| 0.035 | 0.604 | 0.149 | Hepatoprotectant | 0.149 0.111 DBMET00726 | DBMET00726 | |
| 0.011 | 0.637 | 0.139 | DNA intercalator | 0.139 0.048 DBMET00726 | DBMET00726 | |
| 0.009 | 0.644 | 0.1 | Cell adhesion molecule inhibitor | 0.1 0.034 DBMET00726 | DBMET00726 | |
| 0.013 | 0.663 | 0.166 | Thrombolytic | 0.166 0.07 DBMET00726 | DBMET00726 | |
| 0.007 | 0.689 | 0.127 | Protein-tyrosine phosphatase inhibitor | 0.127 0.105 DBMET00726 | DBMET00726 | |
| 0.002 | 0.714 | 0.019 | Free fatty acid receptor 1 agonist | 0.019 0.011 DBMET00726 | DBMET00726 | |
| 0.011 | 0.767 | 0.138 | Cell adhesion inhibitor | 0.138 0.054 DBMET00726 | DBMET00726 | |
| 0.004 | 0.788 | 0.06 | Prostaglandin antagonist | 0.06 0.032 DBMET00726 | DBMET00726 | |
| 0.01 | 0.803 | 0.134 | Insulin secretagoues | 0.134 0.092 DBMET00726 | DBMET00726 | |
| 0.005 | 0.804 | 0.074 | Sphingosine 1-phosphate receptor 5 agonist | 0.074 0.014 DBMET00726 | DBMET00726 | |
| 0.003 | 0.814 | 0.021 | Prostaglandin D2 antagonist | 0.021 0.017 DBMET00726 | DBMET00726 | |
| 0.016 | 0.828 | 0.162 | Hypoglycemic | 0.162 0.159 DBMET00726 | DBMET00726 | |
| 0.004 | 0.856 | 0.068 | Peroxisome proliferator-activated receptor gamma agonist | 0.068 0.051 DBMET00726 | DBMET00726 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |